For two rulemaking cycles running, CMS updated it’s policies to expand the number of procedures available in the outpatient setting – but all ASCs may not be seizing opportunities for service line expansion evenly. But two months of reporting from…
The Latest
Four of the 15 healthcare-industry billionaires on Forbes’ 2026 Forbes 400 list are physicians, and the rest built their fortunes as executives, founders or heirs in hospitals, medical devices, drug distribution and pharma. Here are the physicians who made the…
Pathologists, hematologist-oncologists and podiatrists are the most likely physicians to search for a job in another state, according to a Sept. 4 blog post from Marit Health. The analysis of job search behavior from 18,000 clinicians found wide variation in…
Healthcare Realty has acquired $58 million of medical real estate in Summerville, S.C., and Chapel Hill, N.C., from Hammes, Connect CRE reported Sept. 14. The properties include Summerville Medical Campus, a nearly 100,000-square-foot, multi-tenant medical office building anchored by the…
Parker, Ariz.-based Parker Medical Center will close its doors Oct. 16, according to a notice posted on the practice’s website. Keith Shillito, MD, the practice’s physician, said he and his wife, the office manager, decided they could no longer sustain…
In high-cost markets, hospital staff increasingly earn too much to qualify for housing aid yet too little to afford a home near work. The strain lands on operations: longer commutes, harder recruiting, higher turnover and rising labor costs. The scale…
Presented by:
ASCs are rethinking who staffs their operating rooms and how much it costs them to do it as the anesthesia workforce continues to face pressures on both the supply and demand side of the equation. As certified registered nurse anesthetists…
For more than a decade, the ASC industry has absorbed one specialty after another that was once considered too complex for an outpatient setting, from total joint replacements to spine fusions and, more recently, cardiac electrophysiology procedures such as ablation.…
By 2035, the anesthesia monitoring technology alone is expected to be a $7.86 billion market, up from $3.17 billion in 2025, growing at a 9.5% annual clip as more complex cases move into outpatient settings. Medicare’s own numbers already show…
Molecular residual disease (MRD) testing is moving into the next phase of precision oncology, extending molecular insight past diagnosis and treatment selection into post-treatment monitoring, surveillance and survivorship. For health systems, the question is not whether to add another test.…
Oct 13, 2026 12:00 PM - 1:00 PM CDT
Presented by:
Presenter:
- Rick Baehner, MD, Chief Medical Officer, Precision Oncology Abbott Cancer Diagnostics, Clinical Professor of Pathology,, University of California, San Francisco